title: Dermatitis herpetiformis. Part II. Diagnosis, management, and prognosis.
abstract: The prompt recognition of the clinical features of dermatitis herpetiformis (DH) is important, but securing a definitive diagnosis requires further work-up. Recent advances in understanding of the immunologic basis for DH have led to the development and wider availability of serologic testing, which is rapidly becoming an essential part of the diagnosis and management of DH. Part II of this series will detail the diagnosis, treatment, and follow-up for patients with DH, and will particularly focus on recent advances in the field.
authors.affiliation: Section of Dermatology, The University of Chicago, Chicago, Illinois 60637, USA. vrosic@medicine.bsd.uchicago.edu
authors.forename: Diana
authors.initials: D
authors.lastname: Bolotin
authors.forename: Vesna
authors.initials: V
authors.lastname: Petronic-Rosic
mesh_terms: D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D003622:Dapsone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D003874:Dermatitis Herpetiformis / Q000175:diagnosis* / Q000178:diet therapy / Q000276:immunology / Q000628:therapy*; D055050:Diet, Gluten-Free; D006801:Humans; D010348:Patient Care Team; D010808:Physical Examination; D011379:Prognosis; D012698:Serologic Tests; D016896:Treatment Outcome
chemical_list: D000890:Anti-Infective Agents; D003622:Dapsone